Skip to main content
. Author manuscript; available in PMC: 2012 Jun 21.
Published in final edited form as: Lung Cancer. 2007 Jan 18;56(1):97–103. doi: 10.1016/j.lungcan.2006.11.023

Figure 3.

Figure 3

Survival curves in the weak and strong C/EBPα immunohistochemistry (IHC) groups by treatment arm of E3590. A) Overall survival in arm A: radiotherapy; and B) Overall survival in arm B: chemoradiation. The solid line represents the strong IHC (2+ or 3+) group and the dashed line represents the weak IHC group (0 or 1+).